Latest News

START study responds to revised US guidelines for use of ART

CTU paper shortlisted for Paper of the Year

Recruitment to the PIVOT (Protease Inhibitor monotherapy Versus Ongoing Triple Therapy) trial reaches 300!

RE04 trial results – comparing two different treatments for advanced renal cell carcinoma

Knowledge of the current CD4 cell count is sufficient when deciding whether to initiate ART in symptom-free HIV patient